Stuttgart
10.06.26 | 21:56
4,730 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,675 | 4,720 | 10.06. | |
| 4,710 | 4,775 | 10.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2026 | 239 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 03.06. | Median Technologies Announces Successful Upsized Capital Increase of € 50 Million | 636 | Business Wire | Not to be published, distributed or disseminated, directly or indirectly, in the United States of America, Australia, Canada, South Africa and Japan
Great Success of the capital increase with... ► Artikel lesen | |
| 01.06. | Median Technologies Brings Forward Subscription Period of its €50 Million Capital Increase on the Back of Strong Demand from Institutional Investors | 329 | Business Wire | The €50 million capital increase, with a subscription price of €5.00 per New Share launched on May 27, 2026, is already oversubscribed
The Public Offering period, initially scheduled to... ► Artikel lesen | |
| 28.05. | Median Technologies: €40 Million Capital Increase Launched To Support eyonis LCS Expansion | 1 | pulse2.com | ||
| MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 27.05. | Median Technologies Launches a Capital Increase of €40 million, with Potential Upsize to €50 million, to Support the Deployment of eyonis LCS in the U.S. and Europe and Advance New Clinical Indications for Its Proprietary eyonis... | 1.055 | Business Wire | Share capital increase without shareholders' preferential subscription rights, to be carried out by way of an issue of ordinary shares in the framework of a public offering, for an amount of approximately... ► Artikel lesen | |
| 26.05. | Median Technologies to Showcase iCRO's Central and AI-powered Imaging Services for Oncology Clinical Trials at ASCO 2026 | 252 | Business Wire | Median is a leading provider of imaging services to the world's top oncology pharma companies
Median will host two presentation sessions to introduce its new solutions for radiopharmaceutical... ► Artikel lesen | |
| 21.05. | Median Technologies Announces the Availability of the Preparatory Documents for the Annual Shareholders' Ordinary and Extraordinary General Meeting on June 10, 2026 | 474 | Business Wire | Regulatory News:
The shareholders of Median Technologies (FR0011049824, ALMDT, "Median" or "The Company") are invited to participate in the Annual Shareholders' Ordinary and Extraordinary General... ► Artikel lesen | |
| 04.05. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30, 2026 | 280 | Business Wire | Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 23.04. | Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights | 741 | Business Wire | eyonis LCS 510(k) clearance sets stage for commercialization in the United States
New leadership of U.S. subsidiary and collaboration with Tempus accelerate rollout
28% reduction... ► Artikel lesen | |
| 07.04. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2026 | 367 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 18.03. | Median Technologies Achieves ISO 13485:2016 Certification for eyonis Medical Device Quality Management System | 538 | Business Wire | Certification of a robust and compliant Quality Management System for AI-based Software as Medical Devices, as per internationally recognized medical device regulatory standards
Pledge... ► Artikel lesen | |
| 13.03. | Median Technologies Meets the Eligibility Conditions for the PEA-PME Scheme | 450 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as... ► Artikel lesen | |
| 09.03. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2026 | 343 | Business Wire | Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 02.03. | Median Technologies to Showcase eyonis LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology | 459 | Business Wire | eyonis LCS commercial launch is ongoing in U.S. following FDA 510(k) clearance
CE-marking regulatory process is on-going with a decision expected in Q2 2026 that could trigger commercial... ► Artikel lesen | |
| 27.02. | Median Technologies to present at the TD Cowen 46th Annual Health Care Conference | 413 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for... ► Artikel lesen | |
| 23.02. | Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis LCS | 333 | Business Wire | Webcasts on February 26, 2026, at 5:45 pm CET (held in French): sign-up link and 6:45 pm CET/12:45 pm ET (held in English): sign-up link
Regulatory News:
Median Technologies (FR0011049824, ALMDT... ► Artikel lesen | |
| 18.02. | Median Technologies: FDA Clearance Sets Stage for U.S. Commercialization of eyonis LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc. | 634 | Business Wire | Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis LCS
Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway... ► Artikel lesen | |
| 12.02. | Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis LCS Software as a Medical Device in the United States | 493 | Business Wire | The collaboration follows FDA 510(k) clearance for eyonis LCS and aims to integrate high-performance lung cancer screening detection and diagnosis device into the clinical workflow through the Tempus... ► Artikel lesen | |
| 11.02. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31, 2026 | 400 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 09.02. | Median Technologies receives FDA clearance for lung cancer AI tool | 8 | Investing.com |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALANTIR TECHNOLOGIES | 112,82 | -0,05 % | Palantir: Wenn starkes Wachstum an seine Grenzen stößt - was Anleger jetzt wissen müssen | Palantir hat sich operativ deutlich verbessert, steht jedoch vor einem klar erkennbaren Wachstumslimit. Ein Analystenbeitrag auf Seeking Alpha sieht die Budgetgrenzen der Kunden als sichtbar erreicht... ► Artikel lesen | |
| ORACLE | 177,84 | +0,10 % | RBC stuft ORACLE CORP auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für Oracle vor Zahlen von 160 auf 190 US-Dollar angehoben, die Einstufung aber auf "Sector Perform" belassen. Der Softwarekonzern... ► Artikel lesen | |
| SHOPIFY | 94,34 | +0,67 % | Shopify (SHOP) Fell With Software Sell Off | ||
| D-WAVE QUANTUM | 20,250 | +0,45 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| CROWDSTRIKE | 561,70 | +0,11 % | Iran-Krieg: DAX schwächer - Broadcom, Crowdstrike, Hochtief, Porsche SE, RWE, Bayer, SAP im ... | Der DAX hat am Mittwoch deutlich Federn lassen müssen. Aus dem Handel ging er am Ende mit einem Minus von 1,3 Prozent bei 24.795,94 Zählern. Und auch der Start in den Donnerstag sieht schwächer aus.... ► Artikel lesen | |
| ATOSS SOFTWARE | 77,80 | 0,00 % | ATOSS SOFTWARE SE zündet - ich sehe jetzt Kursexplosion! | ||
| ZOOM COMMUNICATIONS | 81,60 | +0,25 % | Zoom-Aktie nach Anthropics-Einstieg: Innovationserzählung trifft auf strukturellen Gegenwind im Kerngeschäft | Zoom steht trotz eines strategisch bedeutsamen Investments in das KI-Start-up Anthropic vor strukturellen Herausforderungen im Kerngeschäft mit Sitzlizenzen. Das Kurspotenzial erscheint begrenzt, da... ► Artikel lesen | |
| VEEVA SYSTEMS | 143,00 | +0,74 % | Blue Mountain erweitert das RAM Connect-Ökosystem um neue Integrationen für SAP, Veeva, Sware und ZenQMS | Die neueste Version von RAM Connect stärkt die digitale Vernetzung zwischen Wartungs-, Kalibrierungs-, Qualitäts-, Validierungs- und Compliance-Systemen für Hersteller in der Life-Sciences-BrancheSTATE... ► Artikel lesen | |
| BRAINCHIP | 0,104 | -1,24 % | BRAINCHIP HOLDINGS LTD - Ruhe als strategische Phase | ||
| GEN DIGITAL | 21,555 | +1,03 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| VERSES AI | 0,466 | -4,51 % | VERSES AI Inc.: VERSES AI Corporation Restructures to Focus on Core Target Market | VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next-generation... ► Artikel lesen | |
| GRAB | 2,867 | +1,02 % | Grab to fund onboarding packages for 70 new F&B operators | ||
| SENTINELONE | 12,805 | -0,19 % | The SentinelOne Stock Correction Is Overdone as the Singularity Platform Drives Steady Growth | ||
| TREND MICRO | 33,140 | +0,18 % | TrendAI tritt Anthropics Project Glasswing bei | ||
| MITEK SYSTEMS | 13,360 | -3,68 % | Mitek and Synectics Solutions Partner to Help UK Insurers Tackle Rising Digital Fraud While Expanding Fair Access to Insurance | Real-time identity verification and consortium fraud intelligence combined to improve onboarding risk decisions
Mitek (NASDAQ: MITK) and Synectics Solutions have partnered to help UK insurers detect... ► Artikel lesen |
Das Unternehmen MEDIAN TECHNOLOGIES kann der Branche Software zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 4,730 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDIAN TECHNOLOGIES finden Sie auf Wallstreet Online.